N-aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones are disclosed. These compounds possess antidepressant activity.

Patent
   4526786
Priority
Jun 09 1978
Filed
Jun 16 1982
Issued
Jul 02 1985
Expiry
Jul 02 2002
Assg.orig
Entity
Large
14
3
EXPIRED
6. A compound having the formula ##STR264## in which R is selected from the group consisting of n-butoxy, cyclopentylmethoxy, 2-cyanoethoxy and ##STR265## in which R14 is 3-Cl or 3-NO2.
1. A compound having the formula ##STR252## is selected from the group consisting of ##STR253## and R is selected from the group consisting of cyanomethoxy, 2-cyanoethoxy, ##STR254## in which R14 is H, 3-Cl, 4-F, 3-CN or 3-NO2, and ##STR255##
7. A compound having the formula ##STR266## is selected from the group consisting of ##STR267## and R is selected from the group consisting of cyclopentylmethoxy, cyclohexylmethoxy, cyanomethoxy, 2-cyanoethoxy, ##STR268## in which R14 is H, 3-Cl, 4-F, 3-CN or 3-NO2, and ##STR269##
2. A compound as claimed in claim 1 in which ##STR256## is --NH2 and R is ##STR257##
3. A compound as claimed in claim 1 in which ##STR258## is --NH2.
4. A compound as claimed in claim 1 in which ##STR259## and R is selected from the group consisting of n-butoxy, 3-methylbutoxy, cyclopentylmethoxy, cyclohexylmethoxy and ##STR260## in which R14 is H, 3-Cl, 3-NO2 or 4-F.
5. A compound as claimed in claim 1 in which ##STR261## is selected from the group consisting of ##STR262## and R is ##STR263##
8. A pharmaceutical composition for treating depression comprising a therapeutically effective amount of a compound as claimed in claim 1 and a pharmacologically acceptable carrier.
9. A pharmaceutical composition for treating depression comprising a therapeutically effective amount of a compound as claimed in claim 7 and a pharmacologically acceptable carrier.
10. A pharmaceutical composition for treating depression comprising a therapeutically effective amount of a compound as claimed in claim 6 and a pharmacologically acceptable carrier.

This is a division of application Ser. No. 45,143 filed June 4, 1979, now U.S. Pat. No. 4,348,393, issued 9-7-82.

The present invention relates to N-aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones, their process of preparation and their therapeutic application.

The compounds of the invention have the formula: ##STR1## in which the parameters (X, A, R1) take anyone of the following values:

(a) (O,O,H), R2 is:

either an ester group of formula --CH2 --OCOR3 in which R3 is a linear or branched alkyl moiety having from 1 to 8 carbon atoms, a cyclohexyl group, a phenyl nucleus, a methoxymethyl or a phenyloxymethyl group; and R is in para position and is anyone of the following groups: n-butyloxy, methyl-3 butyloxy, cyclopentylmethoxy, cyclohexylmethoxy, cyano-2 ethoxy, cyanomethoxy, benzyloxy of formula ##STR2## in which R4 is a hydrogen or a chlorine atom in meta position, a fluorine atom in meta or para position, or a cyano or nitro group in meta position; disubstituted para-benzyloxy group of formula ##STR3## in which R5 is a chlorine atom or a cyano group; or an ether group of formula --CH2 --OR6 in which R6 is a linear or branched alkyl group having from 1 to 5 carbon atoms, a cyclohexyl, allyl, propargyl or methoxymethyl group; and R is the methyl group in meta position, or is any one of the following groups located in para position:

linear or branched alkyloxy having from 4 to 6 carbon atoms,

cycloalkylmethyloxy the cycloalkyl moiety of which has from 4 to 7 carbon atoms,

(methyl-1 cyclopentyl-1)methyloxy,

(cyclopentene-1 yl)methyloxy,

(cyclohexene-1 yl)methyloxy,

(butene-2)oxy,

(methyl-3 butene-2)oxy,

chloro-4 butyloxy,

cyano-2 ethoxy; cyano-3 propoxy or cyano-4 butoxy,

oxo-2 propoxy,

(oxo-4 cyclohexyl-1)methoxy,

morpholino-2 ethoxy,

N,N dimethyl amino,

(tetrahydropyranyl-4)methoxy or (tetra hydropyranyl-3)methoxy,

benzyloxy of formula ##STR4## in which R7 is selected from the group consisting of: H, 3-Cl, 4-Cl, 3-F, 4-F, 3-I, 3-Br, 3-CF3, 3-NO2, 4-NO2, 4-CN,

3-cyanobenzyloxy, the corresponding compound of formula (I) having an asymmetric carbon being isolated as a racemic mixture or as two enantiomers or formulae (Ia) and (Ib) having respectively the absolute configuration: R(-) and S(+) ##STR5## disubstituted benzyloxy of formula ##STR6## in which R8 is a chlorine atom, or a cyano or nitro group; disubstituted benzyloxy of formula ##STR7## in which R9 is a chlorine atom or a nitro group; disubstituted benzyloxy of formula ##STR8## in which R5 is a a chlorine atom or a cyano group; 3,5-dichlorobenzyloxy;

substituted or non substituted styryl chain of trans configuration and of formula ##STR9## in which R10 is a hydrogen or chlorine atom, or a cyano or nitro group;

substituted or non substituted styryl chain of cis configuration and of formula ##STR10## in which R11 is a hydrogen atom or a nitro group, ##STR11## or phenethyl chain, or phenyl nucleus;

or an amine group of formula ##STR12## is selected from the group consisting of: --NH2, NH--CH3, NH--C2 H5, NH--<, ##STR13## and R is in para position and is selected from the group consisting of: n-butyloxy, methyl-3 butyloxy, cyclopentylmethoxy, cyclohexylmethoxy, cyanomethoxy or cyano-2 ethoxy group;

benzyloxy group of formula ##STR14## in which R14 has one of the following values: H, 3-Cl, 4-F, 3-CN, 3-NO2 ; or

disubstituted benzyloxy group of formula ##STR15##

(b) (O,CH2,H), R2 is the hydroxymethyl group, and R is the para-(metanitro)benzyloxy group;

(c) (H2,CH2,H), R2 is the hydroxymethyl group and R is the parabenzyloxy group;

(d) (O,S,H), R2 is the methoxymethyl group and R is the para-(metanitro)benzyloxy group;

(e) (S,O,H), R2 is:

either a hydroxymethyl group and R in para position is selected from the group consisting of:

a linear or branched alkyloxy group having from 2 to 5 carbon atoms,

a cyclopentylmethoxy, cyclohexylmethoxy, (cyclohexene-1 yl)methoxy or (tetrahydropyranyl-4)methoxy group,

a cyanomethoxy, cyano-2 ethoxy, cyano-3 propoxy or cyano-4 butoxy group,

a benzyloxy group of formula ##STR16## in which R15 has one of the following values: 3-Cl, 4-Cl, 3-F, 4-F, 3-NO2, 3-CN, 3-CF3, or

a disubstituted benzyloxy group of formula: ##STR17## or an ether group of formula --CH2 --O--R16 in which R16 is a linear or branched alkyl group having from 1 to 3 carbon atoms, and R in para position is selected from the group consisting of:

methyl-3 n-butyloxy, cyclopentylmethoxy, cyclohexylmethoxy or cyano-4 butoxy group),

a benzyloxy group of formula ##STR18## in which R17 is a cyano or nitro group, the cyano-3 nitro-5 benzyloxy group, or

the pyridinyl-3 methoxy group,

or an ester group of formula --CH2 --OCOR18 in which R18 is a methyl or ethyl group and R in para position is the cyclohexylmethoxy group or a benzyloxy group of formula ##STR19## in which R17 is a cyano or nitro group.

(A) The process for preparing the compounds of formula (I) in which the parameters (X,A,R1,R2) represent (O,O,H, CH2 OCOR3), R3 having the same meanings as above, consists in condensing the compounds of formula: ##STR20## in which R19 represents one of the following groups: n-butyloxy; methyl-3 butoxy; cyclopentylmethoxy; cyclohexylmethoxy; cyano-2 ethoxy; cyanomethoxy; benzyloxy of formula ##STR21## with R4 =H, 3-Cl, 3-F, 4-F, 3-CN or 3-NO2 ; and benzyloxy of formula ##STR22## with R5 =Cl or CN, with the acid chlorides of formula:

R3 COCl (III)

in which R3 has the same meanings as above.

This condensation is carried out preferably at room temperature, either in an organic solvent such as chloroform or tetrahydrofuran in the presence of triethylamine, or in pyridine.

The compounds of formula (II), except those in which R19 is the cyano-2 ethoxy group, are prepared according to the method described in Belgian Pat. No. 851 893 (reacting the p-hydroxyphenyl-3 hydroxymethyl-5 oxazolidinone-2 on the suitable chloride, bromide or tosylate).

The compound of formula (II) in which R19 is the cyano-2 ethoxy group is obtained by cyclising, by action of ethyl carbonate, the compound of formula ##STR23## to obtain the compound of formula: ##STR24## which is selectively hydrogenolysed in the presence of palladium on charcoal, in ethanol, preferably at room temperature, to give the compound of formula: ##STR25## which is condensed with acrylonitrile in the presence of triton B, to give the compound of formula: ##STR26## which is then hydrogenolysed in ethanol in the presence of palladium on charcoal, and preferably, of some drops of hydrochloric ethanol.

The compound of formula (IV) is obtained in condensing, in methanol or ethanol, the parabenzyloxyaniline with the benzyloxy-3 epoxy-1,2 propane.

(B) The process for preparing the compounds of formula (I) in which the parameters (X,A,R1) represent (O,O,H), and R2 is an ether group of formula --CH2 --OR6 in which R6 has the same meanings as above consists:

(1) either in submitting the compounds of formula: ##STR27## in which R20 represents the meta-methyl group or one of the following groups in para position: linear or branched alkyloxy having from 4 to 6 carbon atoms; cycloalkylmethoxy the alkyl moiety of which has from 4 to 7 carbon atoms; (methyl-1 cyclopentyl-1)methoxy; butene-2 oxy; methyl-3 butene-2 oxy; (cyclopentene-1 yl)methoxy; (cyclohexene-1 yl)methoxy; morpholino-2 ethoxy; chloro-4 butyloxy; (oxo-4 cyclohexyl-1)methoxy; oxo-2 propoxy; cyano-3 propoxy; cyano-2 ethoxy; cyano-4 butoxy: dimethyl amino; (tetrahydropyranyl-4)methoxy; (tetrahydropyranyl-3)methoxy; benzyloxy of formula ##STR28## in which R7 =H, 3-Cl, 4-Cl, 3-F, 4-F, 3-I, 3-Br, 3-CF3, 3-NO2, 4-NO2, 3-CN, 4-CN; disubstituted benzyloxy of formula: ##STR29## in which R8, R9 and R5 have the same meanings as above; and ##STR30## to a so-called "phase transfer" reaction, in the presence of a catalyst so-called "phase transfer catalyst", and in a basic medium with derivatives of formulae:

(CH3)2 SO4

R6 --Cl or

R6 --I

in which R6 has the same meanings as previously.

The used catalyst is preferably the benzyltributylammonium bromide, but it can be chosen among the catalysts mentioned in the following documents: Synthesis 1973, 441, and Angewandte Chemie, Edit. Int. Vol. 13, 170, (1974).

The used base is preferably aqueous soda and the reaction can be carried out in an organic solvent such as methylene chloride or benzene.

The compounds of formula (IIa), except those in which R20 represents the cyano-2 ethoxy group which is obtained by hydrogenolysing the compound for formula (VII), are prepared according to the method described in Belgian Pat. No. 851 893.

(2) or in condensing the compounds of formula: ##STR31## in which R'6 is a linear or branched alkyl group having from 1 to 5 carbon atoms, a cyclohexyl or a methoxymethyl group, with the chlorides or tosylates of formula:

R'20 --Cl

R'20 --OTs

in which R'20 has the same meanings as R20 except for the meta-methyl and para-cyano-2 ethoxy groups.

The condensation is carried out with reflux in acetone or acetonitrile in the presence of potassium carbonate, or with reflux in dimethylformamide in the presence of sodium hydride.

The compounds of formula (VIII) are obtained by hydrogenolysing in the presence of palladium on charcoal, the compounds of formula: ##STR32## in which R'6 has the same meanings as in formula (VIII).

The compounds of formula (IX) are obtained by a three stages synthesis which consists in condensing the chlorhydrine of formula: ##STR33## in which R'6 has the same meanings as in formula (IX) with phosgene, then in condensing the product thus obtained with parabenzyloxyaniline and at last in cyclising the obtained product by means of ethanolic potash or sodium methylate in methanolic solution.

(3) or, when R is the cyano-2 ethoxy group, in reacting acrylonitrile in the presence of triton B with the compound of formula (VIII);

(4) or, according to the process described above for the synthesis of compounds of formula (IX), but with chlorohydrines of formula (X) and anilines of formula: ##STR34## in which R21 represents a trans styryl group of formula ##STR35## with R10 =H, Cl, CN, NO2 ; a cis styryl group of formula ##STR36## with R11 =H, NO2 ; a stylbene group ##STR37## a phenethyl group; or a phenyl group; instead of the parabenzyloxyaniline;

(5) or, when (I) is (Ia) in submitting to a "phase transfer" reaction the compound of absolute configuration R(-) and having the formula: ##STR38## in presence of a phase transfer catalyst, of (CH3)2 SO4 and in a basic medium.

The compound of formula (IIb) is obtained by reacting the metacyanobenzyl chloride with the compound of formula: ##STR39## which is obtained by hydrogenolysing in the presence of palladium on charcoal, the compound of absolute configuration R(-) and having the formula: ##STR40##

This last compound is obtained according to the method described for the synthesis of compounds of formula (IX) but from parabenzyloxyaniline and benzyloxy-3 paratosyloxy-1 propanol-2 having the S(+) configuration, instead of the compound of formula (X).

(6) or, when (I) is (Ib), according to the process described for the synthesis of compounds of formula (IX), but by using the p-(cyano-3)benzyloxyaniline instead of parabenzyloxyaniline and methoxy-3 paratosyloxy-1 propanol-2 of absolute configuration R and of formula: ##STR41## instead of the compound of formula (X).

The compound of formula (XII) is obtained by reacting the tosyl chloride, in a benzene medium and in the presence of pyridine, with the methoxy-3 propane diol-1,2 of absolute configuration S and of formula: ##STR42##

This compound of formula (XIII) is obtained by catalytically debenzylating, in the presence of palladium on charcoal, the compound of absolute configuration R and of formula: ##STR43##

The compound of formula (XIV) is obtained by opening, with methanol in the presence of boron trifluoride etherate, benzyloxy-1 epoxy-2,3 propane having the absolute configuration S(+) and described in J. Chem. Soc. 1967 1021.

(C) The process for preparing the compounds of formula (I) in which the parameters (X,A,R1) represent (O,O,H), R2 represents an amine group of formula ##STR44## has the same meanings as above, consists in reacting amines of formula ##STR45## with the compounds of formula: ##STR46## in which R22 is a n-butyloxy, methyl-3 butyloxy, cyclopentylmethoxy, cyclohexylmethoxy, cyanomethoxy, cyanoethoxy group, benzyloxy group of formula ##STR47## in which R14 has the same meanings as above or a chloro-3 nitro-5 benzyloxy group.

The compounds of formula (XV) are obtained by action of mesyl chloride on the compounds of formula: ##STR48## in which R22 has the same meanings as in formula (XV), the compounds of formula (IId) being obtained according to the process described in Belgian Pat. No. 851 893.

(D) The process for preparing the compounds of formula (I) in which the parameters (X, A, R1) represent (O,CH2,H), R2 represents the hydroxymethyl group and R represents the para(metanitro)benzyloxy group consists in reacting the metanitrobenzyl chloride on the compound of formula: ##STR49## obtained by hydrogenolysing in the presence of palladium on charcoal, the compound of formula: ##STR50## obtained by reducing with lithium borohydride the compound of formula: ##STR51##

The compound of formula (XVIII) is obtained by esterifying with ethanol in the presence of sulfuric acid, the compound of formula: ##STR52## which is obtained by condensing parabenzyloxyaniline with itaconic acid.

The process for preparing the compound of formula (I) in which (X,A,R1) is (H2, CH2,H), R2 is the hydroxymethyl group and R is the parabenzyloxy group consists in reducing with lithium aluminium hydride the compound of formula (XVIII).

(E) The process for preparing the compound of formula (I) in which (X, A,R1) is (O,S,H), R2 is the methoxymethyl group and R is the para(metanitro)benzyloxy group consists in cyclising with the phosgene the compound of formula: ##STR53## obtained by condensing para(metanitro)benzyloxyaniline with methoxy methyl-2 thiooxirane.

(F) The process for preparing the compounds of formula (I) in which the parameters (X,A,R1) are (S,O,H), R2 is a hydroxymethyl group or a --CH2 OR16 group in which R16 has the same meanings as above, consists in cyclising with thiophosgene,

either compounds of formula: ##STR54## in which R23 represents linear or branched alkyloxy group having from 2 to 5 carbon atoms, cyclopentylmethoxy, cyclohexylmethoxy, (cyclohexene-1 yl)methoxy, (tetrahydropyrannyl-4)methoxy, cyanomethoxy, cyano-2 ethoxy, cyano-3 propoxy, cyano-4 butoxy group, benzyloxy group of formula ##STR55## with R15 =3-Cl, 4-Cl, 3-F, 4-F, 3-NO2, 3-CN or 3-CF3, (chloro-3 cyano-5)benzyloxy or (cyano-3 fluoro-4)benzyloxy group,

or compounds of formula: ##STR56## in which R16 has the same meanings as above and R24 represents a methyl-3 butoxy; cyclopentylmethoxy, cyclohexylmethoxy, cyano-4 butoxy group, a benzyloxy group of formula ##STR57## with R17 =CN or NO2, a (cyano-3 nitro-5)benzyloxy or (pyridinyl-3)methoxy group.

The compounds of formula (XXI) are obtained by condensing glycidol and anilines of formula: ##STR58## in which R23 has the same meanings as in formula (XXI), and the compounds of formula (XXII) are obtained by condensing anilines of formula: ##STR59## in which R24 has the same meanings as in formula (XXII) with the chlorohydrines of formula: ##STR60## in which R16 has the same meanings as above.

(G) The process for preparing the compounds of formula (I) in which the parameters (X,A,R1) represent (S,O,H) and R2 is an ester group of formula R18 COOCH2 in which R18 has the same meaning as above, consists in condensing the acid chloride of formula:

R18 COCl (IIIa)

in which R18 is as above, with the compounds of formula (I) having the following structure: ##STR61## in which R25 represents a cyclohexylmethoxy group or a benzyloxy group of formula ##STR62## with R17 =CN or NO2, according to the process described under chapter (A) above. The compounds (Ic) are obtained according to the process described under chapter (F) above.

The following preparations are given by way of example to illustrate the invention.

PAC Para (meta-nitrobenzyloxy)phenyl-3 acetoxy-methyl-5 oxazolidinone-2 [I]

A solution of 10.5 g of para(metanitrobenzyloxy)phenyl-3 hydroxy methyl-5 oxazolidinone-2 [(II), mp=135°C], 2.5 cm3 of acetyl chloride and 4.5 cm3 of triethylamine in 100 cm3 of chloroform was left for 12 hours at room temperature. Then, the solution was diluted in water, the chloroformic phase was decanted, the solvent was evaporated and the residue was recrystallized in pure alcohol. 8 g of product were obtained.

Yield: 72%

Melting point: 126°C

Empirical formula: C19 H18 N2 O7

Molecular weight: 386.35

Elementary Analysis:

______________________________________
C H N
______________________________________
Calculated (%)
59.06 4.70 7.25
Found (%) 59.10 4.56 6.95
______________________________________

With the same method, but from the corresponding reagents, the compounds of formula (I) were prepared, given in table I and bearing code numbers: 1 to 44; 103 to 108; 115, 117, 120 to 141; 178 and 208.

PAC (paracyano-2 ethoxyphenyl)-3-hydroxymethyl-5 oxazolidinone-2 [II] ##STR63##

This compound was obtained following a method in which a mixture of 0.2 mole of the compound of formula: ##STR64## 200 ml of ethyl carbonate and 8 ml of triethylamine is heated at 100°-110°C for 5 hours, then the product was filtered and recrystallized in pure alcohol.

Yield: 80%

Melting point: 126°C

Empirical formula: C24 H23 NO4

Molecular weight: 389.43

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
74.02 5.95 3.60
Found (%) 73.87 6.14 3.89
______________________________________

A suspension of 18 g (0.046 mole) of the compound obtained in the first step and 2 g of 10% palladium charcoal in 400 ml of pure alcohol was hydrogenolysed in autoclave, at room temperature and under a hydrogen pressure of 4-5 kg. Then the mixture was filtered, the solvent evaporated and the residue recrystallized in pure alcohol.

Yield: 73%

Melting point: 153°C

Empirical formula: C17 H17 NO4

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
68.21 5.73 4.68
Found (%) 68.38 5.62 4.46
______________________________________

By the same process, but from the corresponding reagents, the compound of formula (IIc) [mp=188°C, Empirical formula: C10 H11 NO4 ] (from compound of formula (Va)); and the compound of formula (XVI) [mp=196°C, empirical formula: C11 H13 NO3 ] (from compound of formula (XVII)) were obtained.

A solution of 13 g (0.03 mole) of the compound prepared in the second step, in 45 g (0.86 mole) of acrylonitrile in the presence of 1 ml of triton B (40% in methanol), was brought to reflux for 15 hours. Then the acrylonitrile in excess was evaporated, the residue was taken up in 100 ml of N soda and filtered, the precipitate was washed with water then with ether and recrystallized in methanol.

Yield: 60%

Melting point: 112°C

Empirical formula: C20 H20 N2 O4

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
68.17 5.72 7.95
Found (%) 67.89 5.66 8.21
______________________________________

By the same method, but from the corresponding reagents, the compounds of formula (I) were prepared, given in table (I) and bearing code numbers 52 to 54 and 145 to 147.

Fourth step: (p-cyano-2 ethoxyphenyl)-3 hydroxymethyl-5 oxazolidinone-2 (II) ##STR65##

A suspension of 3.5 g (0.01 mole) of (p-cyano-2 ethoxyphenyl)-3-benzyloxymethyl-5 oxazolidinone-2, obtained in the preceding step, 0.4 g of 10% palladium charcoal and 0.05 ml of 7.5N chlorhydric ethanol in 250 ml of dioxane, was hydrogenolysed in an autoclave, at a pressure of 1 kg of hydrogen and at room temperature. The mixture was filtered, the residue was purified by chromatography on a silica column. Eluted with the mixture chloroform-acetone 50/50, the product was obtained which was recrystallized in pure alcohol. Weight: 1 g.

Yield: 39%

Melting point: 131°C

Empirical formula: C13 H14 N2 O4

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
59.53 5.38 10.68
Found (%) 59.06 5.24 10.37
______________________________________
PAC para (meta-nitrobenzyloxy) phenyl-3 methoxymethyl-5 oxazolidinone-2 (I)

A mixture of 10.3 g of para (metanitrobenzyloxy) phenyl-3 hydroxymethyl-5 oxazolidinone (IIa), 10.7 g of benzyltributylammonium bromide, 14.2 g of methyl iodide and 1.8 g of NaOH in 200 ml of water and 280 ml of methylene chloride, was brought to reflux for 50 hours. Then the mixture was decanted, the organic layer washed with water, the solvent evaporated, the residue taken up in ethyl acetate, the filtrate was filtered and chromatographied on a silica column; eluted with chloroform, 6.9 g of the product was obtained which was recrystallized in isopropanol.

Yield: 62%

Melting point: 78°C

Empirical formula: C18 H18 N2 O6

Molecular weight: 358.34

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
60.33 5.06 7.82
Found (%) 60.52 5.10 7.92
______________________________________

By the same method, but from the corresponding reagents, the compounds of formula (I) were prepared, given in table (I) and bearing code numbers 45, 46, 55 to 57; 59, 64 to 73; 109 to 112; 142 to 156; 159 to 169; 179 to 186; 188, 197, 198 and 199 (Ia)

PAC para-n-butyloxy phenyl-3-isopropyloxymethyl-5 oxazolidinone-2 (I) PAC First step: para benzyloxyphenyl-3 isopropyl oxymethyl-5 oxazolidinone-2 (IX)

To a solution of 59 g of phosgene in 560 ml of dichloroethane was added 83.4 g of chloro-1 isopropyloxy-3 propanol-2 (X), then in 30 minutes a solution of 81.9 g of N,N-diethylaniline in 160 ml of dichloroethane. The mixture was heated to 50°C for 2 hours, 250 ml of water was added, the organic layer was decanted and added in 30 minutes on 217.5 g of para benzyloxyaniline. The mixture was brought to reflux for 3 hours, filtered, washed with a 1N hydrochloric acid solution, with water, dried, the solvent was evaporated and the residue was recrystallized in ethanol. 165.5 g of the product were obtained.

Yield: 81%

Melting point: 107°C

NMR spectrum: δppm (DMSO):

______________________________________
9.80,s, NHCOO 1 proton
7.40,s, and 5.08,s: 7 protons
7.18,m, aromatic protons 4 protons
##STR66## 1 proton
3.85,d, (J = 5Hz) CH2O
2 protons
3.59,m, ClCH2CH 3 protons
##STR67## 6 protons
______________________________________

IR spectrum: band NH--COO at 1700 and 3305 cm-1

A solution of 165.5 g of this compound and 29.3 g of potash in 2.4 liters of ethanol was brought to 50°C for 3 hours. Then the solvent was evaporated, the residue was taken up in chloroform, washed with water, dried and the solvent was evaporated. The residue was crystallized in ether and recrystallized in dioxan. 113 g of product were obtained.

Yield: 75%

Melting point: 110°C

Empirical formula: C20 H23 NO4

Molecular weight: 341.4

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
70.36 6.79 4.10
Found (%) 70.14 6.49 4.22
______________________________________

By the same method, but from the corresponding reagents, the compounds of formula (IX) were prepared, given in table (II) and bearing code numbers 226 to 229; as well as:

the compounds of formula (I) given in table I and bearing code numbers 187,189 to 196,

the compound of formula (Ib) given in table I and bearing code number 20, and

the compound of formula (Va): mp=100°C; Yield: 93%;

Empirical formula: C24 H23 NO4 ; [α]D21 =-33°5 (C=1, CH2 Cl2)

PAC Code number: 221

85 g of the compound prepared in the first step in 1700 ml of dioxane and 15 ml of 6.5N hydrochloric alcohol, in the presence of 8.5 g of 10% palladium charcoal, were hydrogenolysed in an autoclave at a pressure of 6 kg for 6 hours. Then the mixture was filtered, the solvent was evaporated, the residue was crystallized in ether and recrystallized in toluene. 43.7 g of product were obtained.

Yield: 70%

Melting point: 93°C

Empirical formula: C13 H17 NO4

Molecular weight: 251.3

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
62.14 6.82 5.57
Found (%) 62.14 6.80 5.56
______________________________________

By the same method, but from the corresponding reagents, the compounds of formula (VIII) were prepared, given in table III and bearing code numbers: 222 to 224 and 230 to 232.

PAC Code number: 47

To a solution of 8.7 g of the compound obtained in the preceding step in 150 ml of dimethyl formamide, was added 1.68 g of sodium hydride (50%), then 9.7 g of n-butyl chloride. The mixture was brought to 100°C for 2 hours and 30 mn, then the solvent was evaporated, the residue was taken up in chloroform, washed with water, dried, the solvent was evaporated, the residue was crystallized in isopropyl ether and recrystallized in isopropanol. 7.8 g of product were obtained.

Yield: 73%

Melting point: 77°C

Empirical formula: C17 H25 NO4

Molecular weight: 307.4

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
66.42 8.20 4.56
Found (%) 66.19 8.27 4.36
______________________________________

By the same method, but from the corresponding reagents, the compounds of formula (I) were prepared, given in table I and bearing the following code numbers: 48, 50, 51, 58, 60, 62, 63, 142, 143, 152, 153, 157, 158, 160, 99 and 234, as well as the compound of formula (IIb): mp=132°C; Yield: 97%; [α]D20 =-79°2 (C=1, pyridine): Empirical formula: C18 H16 N2 O4 ; Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
66.66 4.97 8.64
Found (%) 66.54 5.01 8.54
______________________________________
PAC p-toluene sulfonyloxy-1 hydroxy-2 methoxy-3 propane (R configuration) (XII)

To a solution of 4.14 g of benzyloxy-3 epoxy-1,2 propane in 40 ml of methanol, cooled to 5°C, were added 3 drops of boron trifluoride etherate. Then the mixture is left so as to reach slowly the room temperature (3 hours). A few gms sodium bicarbonate was added, the solvent was evaporated, the residue was taken up in 200 ml of water, extracted with methylene chloride, dried on sodium sulfate and the solvent was evaporated. The residue was chromatographed by high performance liquid chromatography (HPLC) (SiO2 15-25μ), the elution agent being a mixture of ethyl acetate (60%) and n-heptane (40%), and distillated BP0.1 =175°C 70% of product were obtained.

[α]D20 =+44°3 (C=5, ethanol). Empirical formula: C11 H16 O3

A solution of 4.44 g of the compound obtained in the first step, in 200 ml of ethanol and 1 drop of hydrochloric ethanol, was hydrogenolised at a pressure of 5 kg and a temperature of 30°C, in the presence of 10% palladium charcoal. Then the mixture was filtered, a few gms bicarbonate was added to the filtrate, the solvent was evaporated, the residue was taken up in ether, washed with water, dried on sodium sulfate, and the solvent was evaporated. 2.37 g of product were obtained after HPCL (SiO2) of the crude product, the elution agent being a mixture of ethylacetate (60%) and n-heptane (40%).

To a solution of 2.37 g of the compound obtained at the preceding step, in 10 ml of pyridine, cooled at 0°C, was slowly added a solution of 4.27 g of tosyl chloride in 50 ml of benzene. Then the mixture was left for 40 hours at room temperature, diluted with ether, filtered and the filtrate was washed with 1N hydrochloric acid, then with water and with an aqueous solution of sodium bicarbonate until neutrality. Then it was dried on sodium sulfate and the solvent was evaporated. The residue was chromatographed by HPLC (elution agent: ethyl acetate: 60%; n-heptane 40%). Yield: 53%. The product obtained was directly used in the synthesis of the compound of formula (Ib) according to the method described in the first step of example 4.

PAC para benzyloxyphenyl-3 N-methylaminomethyl-5 oxazolidinone-2 (I) PAC First step: mesylate of parabenzyloxyphenyl-3 hydroxymethyl-5 oxazolidinone-2 (XV)

To a solution of 28.5 g of para benzyloxyphenyl-3 hydroxymethyl-5 oxazolidinone-2 (IId) in 27 ml of triethylamine and 750 ml of methylene chloride cooled to 5°C, were added 15 ml of mesyl chloride. They were left for 15 minutes in contact, then the solution was concentrated, diluted with water and the precipitate was filtered and recrystallized in acetone. 32 g of product were obtained.

Yield: 90%

Melting point: 163°C

Empirical formula: C18 H19 NO6 S

Molecular weight: 377.41

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
57.28 5.07 3.71
Found (%) 57.30 4.95 3.46
______________________________________

A mixture of 29 g of the compound obtained at the preceding step and 50 g of ammonia in 500 ml of methanol, was heated to 110°C for 6 hours in an autoclave. Then the solvent was evaporated, the residue was taken up in chloroform, washed with water, the solvent was evaporated and the residue was recrystallized in isopropanol. 17 g of product were isolated.

Yield: 74%

Melting point: 124°C

Empirical formula: C17 H18 N2 O3

Molecular weight: 298.33

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
68.44 6.08 9.39
Found (%) 68.25 6.19 8.82
______________________________________

By the same method, but from the corresponding reagents, the compounds of formula (I) were prepared, given in table I and bearing the code numbers: 74 to 86; 170 to 176 and 201 to 207.

PAC N-parabenzyloxyphenyl-1 hydroxymethyl-4 pyrrolidinone-2 (XVII)

A mixture of 46 g of itaconic acid and 70 g of parabenzyloxyaniline in 400 ml of water was brought to reflux, then washed on the filter with chloroform, dried and recrystallized in acetone. 77 g of product were obtained.

Yield: 71%

Melting point: 194°C

Empirical formula: C18 H17 NO4

Molecular weight: 311.32

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
69.44 5.50 4.50
Found (%) 69.69 5.48 4.80
______________________________________

A solution of 84 g of the acid obtained in the first step in 400 ml of ethanol and 6 ml of concentrated sulfuric acid was brought to reflux for 2 hours. Then, it was cooled, the precipitate was filtered, washed with water, dried and recrytallized in isopropanol. 47 g of product were obtained.

Yield: 51%

Melting point: 106°C

Empirical formula: C20 H21 NO4

Molecular weight: 339.38

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
70.78 6.24 4.13
Found (%) 70.96 6.39 4.44
______________________________________

To a mixture of 7.9 g of sodium borohydride and 18 g of lithium bromide in 400 ml of diglyme, were added 70 g of the compound prepared at the preceding step. Then the mixture was brought to 100°C in 50 mn, diluted in 500 g of ice and 50 ml of concentrated hydrochloric acid, extracted with chloroform; the solvent was evaporated, the residue was crystallized in isopropyl ether and recrystallized in toluene. 45 g of product were obtained.

Yield: 72%

Melting point: 110°C

Empirical formula: C18 H19 NO3

Molecular weight: 297.34

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
72.70 6.44 4.71
Found (%) 72.44 6.36 4.68
______________________________________
PAC N-parabenzyloxyphenyl hydroxymethyl-3 pyrrolidine (I)

A solution of 53 g of the compound of formula (XVIII) obtained in example 7, in 300 ml of anhydrous tetrahydrofuran, was added while cooling to 11.8 g of lithium aluminium hydride (pellets) in 1000 ml of tetrahydrofuran. Then it was brought to reflux for 2 hours, then 6.3 ml of water, 4.75 ml of 20% NaOH and 22 ml of water were successively added. It was filtered, the filtrate was evaporated and the residue was crystallized in ethyl acetate. 38 g of product were obtained.

Yield: 85%

Melting point: 87°C

Empirical formula: C18 H21 NO2

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
76.29 7.47 4.94
Found (%) 76.40 7.60 4.65
______________________________________
PAC para (metanitro) benzyloxyphenyl-3 methoxymethyl-5 thiazolidinone-2(I) PAC First step: para (metanitro) benzyloxyanilino-3 methoxy-1 propane thiol-2, oxalate (XX)

To a solution of 48.8 g of para (metanitro) benzyloxyaniline in 700 ml of isopropanol were slightly added 20.8 g of methoxymethyl-2 thiooxirane, and the mixture was brought to reflux for 7 hours. Then the solvent was evaporated, and the residue was chromatographed on a silica column. By eluting with methylene chloride, 38.4 g of an oil were obtained which were dissolved in acetonitrile. A solution of oxalic acid was added to acetonitrile, and the precipitate was filtered.

Yield: 43%

Melting point: 120°C

Empirical formula: C19 H22 N2 O8 S

Molecular weight: 438.45

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
52.04 5.06 6.39
Found (%) 51.79 4.88 6.48
______________________________________
PAC Code number: 219

To a solution of 3 g of phosgene in 90 ml of dichloroethane, cooled to -10°C, was added 4.14 g of potassium carbonate then 6 g of the compound of formula (XX) (base form) obtained in the previous step, dissolved in 50 ml of dichlorethane, while maintaining the temperature between 5° and 10°C Then, it came slowly to room temperature (3 hours), water was added, the organic phase was decanted, dried on sodium sulfate and the solvent was evaporated. The residue was crystallized in isopropyl ether, and recrystallized in isopropyl alcohol. 3 g of product were obtained.

Yield: 47%

Melting point: 74°C

Empirical formula: C18 H18 N2 O5 S

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
57.74 4.85 7.48
Found (%) 57.45 4.97 7.18
______________________________________
PAC para ethoxyphenyl-3 hydroxymethyl-5 oxazolidine thione-2 (I)

To a solution of 9.6 g of paraethoxyanilino-3 propanediol-1,2 (XXI) and 20.5 ml of triethylamine in 100 ml of tetrahydrofuran, were slowly added 5.2 g of thiophosgene while maintaining the temperature to 20°C Then after 4 hours it was filtered, the filtrate was evaporated and the residue chromatographed on a silica column. Eluted with chloroform, 5.3 g of product were obtained.

Yield: 46%

Melting point: 133°C

Empirical formula: C12 H15 NO3 S

Molecular weight: 253.31

Elementary analysis:

______________________________________
C H N
______________________________________
Calculated (%)
56.89 5.97 5.53
Found (%) 56.98 6.14 5.54
______________________________________

By the same method, but from the corresponding reagents, the compounds of formula (I) were prepared, given in table I and bearing code numbers: 88 to 98; 100, 101, 102, 113 to 120; 177 and 208 to 218.

TABLE I
##STR68##
Melting ELEMENTARY ANALYSIS Code Empirical Molecular point Yield
Calculated (%) Obtained (%) Number X A R1 R2 R formula weight
(°C.) (%) C H N C H N
1 Oxygen Oxygen H CH2 OCOCH3 4-OCH2CN C14 H14
N2 O5 290.27 92 72 57.93 4.86 9.65 57.90 4.87 9.42 2 " " "
CH2 OCOEt " C15 H16 N2 O5 304.29 66 81 59.20
5.30 9.21 59.11 5.37 9.06 3 " " " CH2
OCOCH3
##STR69##
" " 68 75 59.20 5.30 9.21 59.03 5.25 9.35 4 " " " CH2 OCOEt "
C16 H18 N2 O5 318.32 66 80 60.37 5.70 8.80 60.44
5.54 8.64
5 " " "
##STR70##
" C17 H20 N2 O5 332.34 72 58 61.43 6.07 8.43 61.14
6.23 8.37 6 " " " CH2 OCOC4 H9n " C18 H22
N2 O5 346.37 65 72 62.41 6.40 8.09 62.70 6.59 7.94 7 " " "
##STR71##
" C18 H22 N2 O5 346.37 90 57 62.41 6.40 8.09 62.29
6.21 7.90
8 " " "
##STR72##
" C20 H24 N2 O5 372.41 104 76 64.50 6.50 7.52
64.35 6.30 7.69 9 " " " CH2 OCOC8 H17n " C22
H30 N2 O5 402.48 75 75 65.65 7.51 6.96 65.41 7.35 6.72 10
" " "
##STR73##
" C20 H18 N2 O5 366.36 150 68 65.56 4.95 7.65
65.27 4.82 7.55 11 " " " CH2 OCOCH3 4 OC4 H9n
C16 H21 NO5 307.34 60 92 62.52 6.89 4.56 62.49 6.90 4.55
12 " " "
##STR74##
" C19 H27 NO5 349.41 82 30 65.31 7.79 4.01 65.04 7.72
3.81 13 " " " CH2
OCOCH3
##STR75##
C18 H23 NO5 333.37 94 85 64.85 6.95 4.20 64.91 7.24 4.05
14 " " " CH2 OCOEt " C19 H25 NO5 347.39 90 82 65.69
7.25 4.03 65.76 7.20 4.35
15 " " "
##STR76##
O " C20 H27 NO5 361.42 78 54 66.46 7.53 3.88 66.21 7.51
3.66 16 " " " CH2 OCOC4 H9n " C21 H29 NO5
375.45 82 72 67.18 7.79 3.73 67.24 8.08 3.58
17 " " "
##STR77##
" C21 H29 NO5 375.45 94 66 67.18 7.79 3.73 67.19 7.92
3.54
18 " " "
##STR78##
" C23 H31 NO5 401.49 100 71 68.80 7.78 3.49 68.51 7.94
3.19 19 " " " CH2 OCOC8 H17n " C25 H37
NO5 431.55 78 62 69.57 8.64 3.25 69.76 8.91 3.10
20 " " "
##STR79##
" C23 H25 NO5 395.44 112 65 69.85 6.37 3.54 69.96 6.64
3.66 21 " " " CH2
OCOCH3
##STR80##
C19 H25 NO5 347.39 102 72 65.69 7.25 4.03 65.96 7.55
3.98 22 " " " CH2 OCOEt " C20 H27 NO5 361.42 80 80
66.46 7.53 3.88 66.68 7.52 4.13 23 " " " CH2
OCOCH3
##STR81##
C19 H19 NO5 341.35 120 76 66.85 5.61 4.10 67.07 5.54
3.86 24 " " " CH2 OCOEt " C20 H21 NO5 355.37 96 82
67.59 5.96 3.94 67.60 6.15 3.92
25 " " "
##STR82##
" C21 H23 NO5 369.40 114 65 68.28 6.28 3.79 68.31 6.40
3.73 26 " " " CH2 OCOC4 H9n " C22 H25 NO5
383.43 86 71 68.91 6.57 3.65 69.02 6.55 3.60
27 " " "
##STR83##
" C 22 H25 NO5 383.43 116 52 68.91 6.57 3.65 69.16 6.63
3.55 28 " " " CH2 OCOC8 H17n " C26 H33
NO5 439.53 95 60 71.04 7.57 3.19 70.97 7.52 2.90
29 " " "
##STR84##
" C24 H21 NO5 403.42 128 69 71.45 5.25 3.47 71.26 5.08
3.15 30 " " " CH2
OCOCH3
##STR85##
C19 H18 ClNO5 375.79 58 85 60.72 4.83 3.73 60.87 4.94
3.62 31 " " " CH2 OCOEt " C20 H20 ClNO5 389.82 82
82 61.62 5.17 3.59 61.64 5.45 3.59
32 " " "
##STR86##
" C21 H22 ClNO5 403.85 88 62 62.45 5.49 3.47 62.30 5.46
3.20 33 " " " CH2 OCOC4 H9n " C22
H24 ClNO5 417.88 95 73 63.23 5.79 3.35 63.27 5.69 3.17 34 "
" "
##STR87##
" " " 92 65 63.23 5.79 3.35 63.22 5.67 3.25 35 " " " CH2
OCOC8 H17n " C26 H32 ClNO5 473.98 74 65 65.88
6.81 2.96 66.11 7.05 3.22 36 " " " CH2
OCOCH3
##STR88##
C19 H18 N2 O7 386.35 126 72 59.06 4.70 7.25 59.10
4.56 6.95 37 " " " CH2 OCOEt " C20 H20 N2 O7
400.38 106 75 59.99 5.03 7.00 59.86 5.03 6.71
38 " " "
##STR89##
" C21 H22 N2 O7 414.40 108 58 60.86 5.35 6.76
60.62 5.45 6.49 39 " " " CH2 OCOC4 H9n " C22
H24 N2 O7 428.43 102 70 61.67 5.65 6.54 61.75 5.69 6.39
40 " " "
##STR90##
" C22 H24 N2 O7 428.43 118 43 61.67 5.65 6.54
61.41 5.88 6.35
41 " " "
##STR91##
" C24 H26 N2 O7 454.46 150 28 63.42 5.77 6.16
63.54 5.83 5.89 42 " " " CH2 OCOC8 H17n " C26
H32 N2 O7 484.53 83 65 64.45 6.66 5.78 64.18 6.82 5.64
43 " " "
##STR92##
" C24 H20 N2 O7 448.42 182 60 64.28 4.50 6.25
64.39 4.39 6.17 44 " " " CH2
OCOEt
##STR93##
C20 H20 FNO5 373.39 77 70 64.33 5.40 3.75 64.28 5.27
3.73 45 " " " CH2 OCH3 3-CH3 C12 H15 NO3
221.25 58 71 65.14 6.83 6.33 65.36 6.66 6.01 46 " " " " 4 OC4
H9 n C15 H21 NO4 279.33 50 57 64.49 7.58 5.01 64.40
7.55 4.79
47 " " "
##STR94##
" C17 H25 NO4 307.38 77 62 66.42 8.20 4.56 66.19 8.27
4.36
48 " " "
##STR95##
" C20 H29 NO4 347.44 53 71 69.13 8.41 4.03 69.30 8.62
3.83 49 " " " CH2
OCH3
##STR96##
C17 H23 NO4 305.36 70 48 66.86 7.59 4.59 66.79 7.47 4.44
50 " " "
##STR97##
" C19 H27 NO4 333.41 66 35 68.44 8.16 4.20 68.54 8.39
4.22
51 " " "
##STR98##
" C22 H31 NO4 373.47 67 59 70.75 8.37 3.75 70.63 8.53
3.85 52 " " " CH2
OCH3
##STR99##
C14 H16 N2 O4 276.28 104 57 60.86 5.84 10.14 60.59
5.50 10.11
53 " " "
##STR100##
" C16 H20 N2 O4 304.34 89 39 63.11 6.62 9.21 63.29
6.73 9.36
54 " " "
##STR101##
" C19 H24 N2 O4 344.39 80 42 66.26 7.02 8.13 66.19
6.88 7.98 55 " " " CH2
OCH3
##STR102##
C18 H25 NO4 319.39 90 63 67.69 7.89 4.39 67.96 7.83 4.39
56 " " " "
##STR103##
C18 H23 NO4 317.37 80 55 68.12 7.30 4.41 68.21 7.61 4.39
57 " " " "
##STR104##
C18 H19 NO4 313.34 90 83 68.99 6.11 4.47 69.19 6.07 4.24
58 " " "
##STR105##
" C20 H23 NO4 341.39 110 75 70.36 6.79 4.10 70.14 6.49
4.22 59 " " " CH2
OCH3
##STR106##
C18 H18 ClNO4 347.79 96 78 62.16 5.22 4.03 61.99 5.11
3.88
60 " " "
##STR107##
" C20 H22 ClNO4 375.84 99 70 63.91 5.90 3.73 63.92 5.90
3.68 61 " " " CH2
OCH3
##STR108##
C18 H18 N2 O6 358.34 78 62 60.33 5.06 7.82 60.52
5.10 7.92
62 " " "
##STR109##
" C20 H22 N2 O6 386.39 74 60 62.16 5.74 7.25 62.16
5.94 7.49
63 " " "
##STR110##
" C23 H26 N2 O6 426.45 78 60 64.77 6.15 6.57 64.51
6.18 6.50 64 " " " CH2
OCH3
##STR111##
C18 H18 FNO4 331.33 106 55 62.25 5.48 4.23 65.37 5.52
4.20
65 " " " "
##STR112##
C19 H18 N2 O4 338.35 88 65 67.44 5.36 8.28 67.41
5.48 8.37
66 " " " "
##STR113##
C19 H18 F3 NO4 381.34 83 60 59.84 4.76 3.67 59.81
4.62 3.70
67 " " " "
##STR114##
C18 H18 FNO4 331.33 79 60 65.25 5.48 4.23 65.20 5.59
4.13
68 " " " "
##STR115##
C18 H18 ClNO4 347.79 107 65 62.16 5.22 4.03 62.02 5.23
4.05 69 " " " CH2
OEt
##STR116##
C19 H20 N2 O6 372.37 50 48 61.28 5.41 7.52 61.10
5.34 7.48 70 " " " CH2 OC3 H7n " C20 H22
N2 O6 386.39 52 75 62.16 5.74 7.25 62.09 5.63 7.06 71 " " "
##STR117##
" C20 H20 N2 O6 384.38 <50 40 62.49 5.24 7.29
62.38 5.12 7.17
72 " " "
##STR118##
" C20 H18 N2 O6 382.36 80 55 62.82 4.75 7.33 62.75
4.76 7.23
73 " " "
##STR119##
" C19 H20 N2 O7 388.37 79 50 58.76 5.19 7.21 58.53
5.26 7.20 74 " " " CH2NHCH3 4 OC4 H9n C15
H22 N2 O3 278.34 56 75 64.72 7.97 10.07 64.57 7.81 10.18
75 " " "
##STR120##
" C16 H24 N2 O3 292.37 68 70 65.73 8.27 9.58 65.73
8.01 9.49
76 " " " CH2NH2
##STR121##
C16 H22 N2 O3 290.35 97 72 66.18 7.64 9.65 66.33
7.96 9.79 77 " " " CH2NHCH3 " C17 H24 N2
O3 304.38 71 70 67.08 7.95 9.20 66.85 7.96 9.14
78 " " "
##STR122##
" C18 H26 N2 O3 318.40 102 65 67.89 8.23 8.80
67.88 8.43 8.73
79 " " " CH2NHCH3
##STR123##
C16 H24 N2 O3 292.37 67 62 65.73 8.27 9.58 65.44
8.23 9.73
80 " " " CH2NH2
##STR124##
C17 H18 N2 O3 298.33 124 74 68.44 6.08 9.39 68.25
6.19 8.82 81 " " " CH2NHCH3 " C18 H20 N2
O3 312.36 88 71 69.21 6.45 8.97 69.51 6.36 8.42
82 " " " CH2NH2
##STR125##
C17 H17 ClN2 O3 332.78 122 70 61.35 5.15 8.42
61.04 5.20 7.66 83 " " " CH2NHCH3 " C18 H19
ClN2 O3 346.81 72 55 62.33 5.52 8.08 61.93 5.35 8.35 84 " " "
CH2NH2
##STR126##
C17 H17 N3 O5 343.33 88 50 59.47 4.99 12.24 59.21
4.71 12.54 85 " " " CH2NHCH3 " C18 H19 N3
O5 357.36 70 75 60.49 5.36 11.76 60.18 5.39 11.83 86 " " "
##STR127##
" C19 H21 N3 O5 371.38 76 72 61.44 5.70 11.32 61.54
5.84 11.29 87 Sulfur " " CH2 OH 4-OEt C12 H15 NO3 S
253.31 133 46 56.89 5.97 5.53 56.98 6.14 5.54 88 " " " " 4 OC3
H7n C13 H17 NO3 S 267.34 84 42 58.40 6.41 5.24 58.55
6.59 5.25 89 " " " " 4 OC4 H9n C14 H19 NO3 S
281.37 95 55 59.76 6.81 4.98 59.64 6.80 4.86
90 " " " "
##STR128##
C17 H23 NO3 S 321.43 100 40 63.52 7.21 4.36 63.27 7.01
4.15
91 " " " "
##STR129##
C15 H21 NO3 S 295.39 80 40 60.99 7.17 4.74 60.75 7.10
4.74
92 " " " "
##STR130##
C12 H11 N2 O3 S 263.29 96 35 54.74 4.21 10.64 54.49
4.64 10.70
93 " " " "
##STR131##
C17 H16 ClNO3 S 349.83 132 40 58.36 4.61 4.00 58.17
4.61 4.00
94 " " " CH2OH
##STR132##
C17 H16 N2 O3 S 360.38 142 37 56.65 4.48 7.77
56.36 4.29 7.58
95 " " " "
##STR133##
C17 H16 ClNO3 S 349.83 163 42 58.36 4.61 4.00 58.31
4.55 3.98
96 " " " "
##STR134##
C17 H16 FNO3 S 333.37 142 55 61.24 4.84 4.20 60.99 4.83
3.92
177 " " " "
##STR135##
" " 153 37 61.24 4.84 4.20 60.94 4.78 4.10
97 " " " "
##STR136##
C18 H16 N2 O3 S 340.39 162 40 63.51 4.74 8.23
63.30 5.00 8.08
98 " " " "
##STR137##
C18 H16 F3 NO3 S 383.38 95 52 56.39 4.21 3.65 56.08
4.14 3.30
99 Oxygen CH2 " "
##STR138##
C18 H18 N2 O5 342.34 96 85 63.15 5.30 8.18 62.98
5.31 7.96
100 Sulfur Oxygen " "
##STR139##
C16 H21 NO3 S 307.40 63 40 62.51 6.89 4.56 62.33 6.90
4.56
101 " " " "
##STR140##
C17 H21 NO3 S 319.41 112 35 63.92 6.63 4.39 63.64 6.76
4.17
102 " " " "
##STR141##
C13 H14 N2 O3 S 278.32 108 43 56.10 5.07 10.07
55.80 5.05 9.87
103 Oxygen " "
##STR142##
##STR143##
C21 H29 NO5 375.45 98 76 67.18 7.79 3.73 67.45 7.87 3.97
104 " " " CH2 OCOC4 H9n " C22 H31 NO5
389.47 96 76 67.84 8.02 3.60 67.91 8.01 3.54
105 " " "
##STR144##
" C22 H31 NO5 389.47 120 73 67.84 8.02 3.60 67.86 8.10
3.45 106 " " " CH2
OCOEt
##STR145##
C20 H20 FNO5 373.37 77 80 64.33 5.40 8.75 64.28 5.27
3.73
107 " " "
##STR146##
" C21 H22 FNO5 387.39 87 62 65.10 5.72 3.62 65.19 5.78
3.60 108 " " " CH2 OCOC4 H9n " C22 H24
FNO5 401.42 92 71 65.82 6.03 3.49 65.83 5.86 3.42 109 " " "
CH2 OEt 4-OC4 H9 n C16 H23 NO4 293.35 64
32 65.50 7.90 4.78 65.63 8.08 4.67 110 " " " CH2 OCH3
##STR147##
C15 H18 N2 O4 290.31 54 68 62.05 6.25 9.65 62.07
6.42 9.61
111 " " " "
##STR148##
C16 H23 NO4 293.35 50 65 65.50 7.90 4.78 65.52 8.03 4.71
112 O O " " 4-O(CH2)4CN C16 H20 N2 O4
304.34 78 50 63.14 6.62 9.21 63.00 6.45 9.09 113 Sulfur Oxygen "
CH2
OH
##STR149##
C17 H15 NClO5 S 394.83 144 58 51.71 3.83 7.10 51.87
3.87 7.34 114 " " " CH2
OCH3
##STR150##
C18 H25 NO3 S 335.45 102 76 64.44 7.51 4.18 64.35 7.46
4.12 115 " " " CH2 OCOCH3 " C19 H25 NO4 S
363.46 96 52 62.78 6.93 3.85 62.64 7.00 3.85 116 " " " CH2
OCH3
##STR151##
C19 H18 N2 O3 S 354.42 108 61 64.38 5.12 7.90
64.37 4.82 7.76 117 " " " CH2
OCOCH3
##STR152##
C19 H18 N2 O6 S 402.42 104 71 56.71 4.51 6.96
56.91 4.28 6.73 118 " " " CH2 OCH3 " C18 H18
N2 O5 S 374.41 97 67 57.74 4.85 7.48 57.60 4.77 7.40 119 " "
" CH2
OH
##STR153##
C16 H21 NO4 S 323.40 117 58 59.42 6.55 4.33 59.17 6.62
4.26 120 " " " CH2
OCOCH3
##STR154##
C20 H18 N2 O4 S 382.43 99 82 62.81 4.74 7.33 62.88
4.67 7.33
121 Oxygen " "
##STR155##
##STR156##
C24 H33 NO5 415.51 128 87 69.37 8.01 3.37 69.33 7.99
3.29 122 " " " CH2 OCOC8
H17n
##STR157##
C26 H39 NO 5 445.58 82 78 70.08 8.82 3.14 70.01 8.67
3.06 123 " " " CH2
OCOCH3
##STR158##
C17 H23 NO5 321.36 80 60 63.53 7.21 4.36 63.66 7.36 4.39
124 " " " CH2 OCOEt " C18 H25 NO5 335.39 78 60
64.46 7.51 4.18 64.35 6.96 4.25
125 " " "
##STR159##
" C20 H29 NO5 363.24 75 74 66.09 8.04 3.85 65.91 7.73
3.80 126 " " " CH2 OCOC8 H17n " C24 H37
NO5 419.54 67 72 68.70 8.89 3.34 68.41 8.93 3.19 127 " " "
##STR160##
##STR161##
C19 H27 NO5 349.41 64 76 65.31 7.79 4.01 65.24 7.88 3.98
128 " " " CH2 OCOC4 H9n " C20 H29 NO5
363.44 70 64 66.09 8.04 3.85 65.96 7.85 3.70
129 " " "
##STR162##
" C22 H31 NO5 389.48 81 68 67.84 8.02 3.60 67.66 8.03
3.71 130 " " " CH2
OCOCH3
##STR163##
C19 H18 FNO5 359.34 60 65 63.50 5.04 3.89 63.28 5.14
3.70 131 " " " CH2 OCOC8 H17n " C26 H32
FNO5 457.52 73 73 68.24 7.05 3.06 68.30 6.96 3.16 132 " " "
CH2
OCOEt
##STR164##
C21 H20 N2 O5 380.39 90 78 66.30 5.30 7.36 66.31
5.52 7.24 138 " " " CH2 OCOC8 H17n " C27 H32
N2 O5 464.54 72 77 69.80 6.94 6.03 69.63 7.15 5.91 134 " " "
##STR165##
##STR166##
C22 H24 N2 O7 428.43 84 40 61.67 5.65 6.54 61.31
5.50 6.28 135 " " " CH2
OCOEt
##STR167##
C20 H20 FNO5 373.37 87 81 64.33 5.40 3.75 64.51 5.12
3.70 136 " " " CH2 OCOC8 H17n " C26 H32
FNO5 457.52 94 83 68.25 7.05 3.06 68.54 6.82 2.97 137 " " "
CH2
OCOEt
##STR168##
C20 H19 ClN2 O7 434.82 104 73 55.24 4.40 6.44
54.93 4.11 6.35 138 " " " CH2 OCOC8 H17n " C26
H31 ClN2 O7 518.99 102 87 60.17 6.02 5.40 60.02 5.82
5.35 139 " " " CH2 OCOC8
H17n
##STR169##
C27 H31 N3 O7 509.54 100 70 63.64 6.13 8.25 63.51
5.99 8.24 140 " " " CH2 OCOEt " C21 H19 N3 O7
425.39 145 50 59.29 4.50 9.88 58.67 4.33 9.78 141 " " " CH2
OCOCH2
OCH3
##STR170##
C20 H20 N2 O8 416.38 125 55 57.69 4.84 6.73 57.63
4.78 6.58 142 " " " CH2 OC3 H7n 4 OC4 H9n
C17 H25 NO4 307.38 72 52 66.42 8.20 4.56 66.35 8.39 4.72
143 " " " "
##STR171##
C19 H27 NO4 333.41 72 63 68.44 8.16 4.20 68.20 7.89 4.11
144 " " " CH2
OCH3
##STR172##
C17 H23 NO5 321.36 100 81 63.53 7.21 4.36 63.36 7.09
4.27 145 " " " CH2 OC3
H7
##STR173##
C16 H20 N2 O4 304.34 40 38 63.14 6.62 9.21 62.96
6.31 8.96 146 " " " CH2
OEt
##STR174##
C18 H25 NO4 319.39 82 79 67.69 7.89 4.39 67.44 7.95 4.36
147 " " " "
##STR175##
C15 H18 N2 O4 290.31 77 41 62.05 6.25 9.65 62.15
5.97 9.61 148 " " " CH2 OCH3 4 OC5 H11n C16
H23 NO4 293.35 58 82 65.50 7.90 4.78 65.45 7.91 4.68 149 " " "
" 4 OC6 H13n C17 H25 NO4 307.38 ≦50 76
66.42 8.20 4.56 66.43 8.12 4.44
150 " " " "
##STR176##
C19 H27 NO4 333.41 71 32 68.44 8.16 4.20 68.39 8.17 4.37
151 " " " "
##STR177##
C14 H17 NO5 279.28 58 85 60.20 6.14 5.02 59.94 6.02 5.11
152 " " " CH2 OC3
H7n
##STR178##
C20 H23 NO4 341.39 105 67 70.36 6.79 4.10 70.17 6.80
3.86
153 " " " "
##STR179##
C20 H22 ClNO4 375.84 75 71 63.91 5.90 3.73 63.95 6.07
3.93 154 " " " CH2
OEt
##STR180##
C19 H21 NO4 327.37 105 85 69.70 6.47 4.28 69.44 6.48
4.23
155 " " " "
##STR181##
C19 H20 ClNO4 361.81 81 82 63.07 5.57 3.87 62.89 5.38
3.80 156 " " " CH2
OCH3
##STR182##
C18 H17 ClN2 O6 392.79 110 64 55.04 4.36 7.13
54.98 4.35 7.17
157 " " "
##STR183##
##STR184##
C21 H24 N2 O6 400.42 76 62 62.99 6.04 7.00 62.68
5.79 6.85
158 " " "
##STR185##
" C22 H26 N2 O6 414.44 70 59 63.75 6.32 6.76 63.49
6.11 6.62 159 " " " CH2
OCH3
##STR186##
C19 H18 N2 O4 338.35 110 78 67.44 5.36 8.28 67.21
5.06 8.20 160 " " " CH2 OC3
H7n
##STR187##
C21 H22 N2 O4 366.40 75 60 68.83 6.05 7.65 68.51
5.98 7.67 161 " " " CH2
OCH3
##STR188##
C19 H17 N3 O6 383.35 163 52 59.63 4.47 10.96 59.50
4.60 10.85 162 " " " CH2
OCH3
##STR189##
C19 H17 FN2 O4 356.34 93 58 64.04 4.81 7.86 63.78
4.80 7.71 163 " " " "
##STR190##
C18 H17 ClFNO4 365.78 90 34 59.10 4.68 3.83 59.40 4.55
4.07
164 " " " "
##STR191##
C18 H17 Cl2 NO4 382.24 93 83 56.56 4.48 3.66 56.45
4.23 3.66
165 " " " "
##STR192##
C18 H18 N2 O6 358.34 134 75 60.33 5.06 7.82 60.08
4.74 7.55
166 " " " "
##STR193##
C18 H17 Cl2 NO4 382.24 76 69 56.56 4.48 3.66 56.47
4.46 3.73 167 " " " CH2
OEt
##STR194##
C20 H20 N2 O4 352.38 ≦50 57 68.17 5.72 7.95
67.93 5.50 8.04 168 " " " CH2
OCH3
##STR195##
C18 H17 ClN2 O6 392.79 94 67 55.04 4.36 7.13 55.04
4.25 7.40
169 " " " "
##STR196##
C18 H17 FN2 O6 376.33 95 61 57.44 4.55 7.44 57.30
4.56 7.29 170 " " " CH2 NH2 4 OC4 H9n C14
H20 N2 O 3 264.32 90 26 63.61 7.63 10.60 63.31 7.47 10.60
171 " " "
##STR197##
##STR198##
C15 H19 N3 O3 289.33 97 17 62.26 6.62 14.52 62.43
6.52 14.46 172 " " " CH2
NH2
##STR199##
C17 H24 N2 O3 304.38 98 43 67.08 7.95 9.20 67.15
7.87 8.92 173 " " " CH2 NHCH3 " C18 H26 N2
O3 318.40 96 32 67.89 8.23 8.30 68.29 8.17 3.30 174 " " " CH2
NH2
##STR200##
C15 H22 N2 O3 278.34 84 45 64.72 7.97 10.07 64.80
7.91 10.16 175 " " " CH2
NHCH3
##STR201##
C18 H19 N2 O3 F 330.35 85 36 65.44 5.80 8.48 65.45
5.82 8.34 176 " " " CH2 NH2 " C17 H17 N2
O2 F 316.32 129 29 44.54 5.42 8.86 64.29 5.46 8.65 178 O O "
##STR202##
##STR203##
C25 H22 N2 O8 478.44 120 64 62.76 4.64 5.86 62.89
4.66 5.84 179 " " " CH2
OCH3
##STR204##
C15 H19 NO4 277.31 63 74 64.96 6.91 5.05 64.67 6.77 4.97
180 " " " "
##STR205##
C13 H18 N2 O3 250.29 92 59 62.38 7.25 11.19 62.45
6.98 10.94
181 " " " "
##STR206##
C17 H24 N2 O5 336.38 92 75 60.70 7.19 8.33 60.47
7.04 8.10
182 " " " "
##STR207##
C17 H23 NO5 321.36 77 22 63.53 7.21 4.36 63.67 7.23 4.38
183 " " " "
##STR208##
C16 H21 NO4 291.34 81 31 65.96 7.27 4.81 66.00 7.46 4.71
184 " " " "
##STR209##
C17 H21 NO4 303.35 83 33 67.31 6.98 4.62 67.01 7.08 4.43
185 " " " "
##STR210##
C16 H21 NO4 291.34 84 78 65.96 7.27 4.81 66.03 7.28 4.59
234 " " " " 4 O(CH2)4 Cl C15 H20 ClNO4 313.77
58 66 57.41 6.42 4.46 57.05 6.50 4.50
186 " " " "
##STR211##
C18 H25 NO4 319.39 77 22 67.69 7.89 9.39 67.62 8.03 4.25
187 " " " "
##STR212##
C19 H19 NO3 309.35 166 26 73.76 6.19 4.53 73.52 6.10
4.38
188 " " " "
##STR213##
C18 H23 NO5 333.37 102 70 64.85 6.95 4.20 64.82 7.11
4.19
189 " " " "
##STR214##
C19 H17 NO3 307.33 120 50 74.25 5.58 4.56 74.18 5.30
4.47
190 " " " "
##STR215##
C19 H18 NO3 Cl 343.80 136 30 66.37 5.28 4.07 66.08 5.24
3.90
191 " " " "
##STR216##
C19 H18 N2 O5 354.35 110 50 64.40 5.12 7.91 64.17
5.24 7.96
192 " " " "
##STR217##
C19 H21 NO3 311.37 74 62 73.29 6.80 4.50 73.17 6.93 4.53
193 " " " "
##STR218##
C19 H19 NO3 309.35 82 60 73.16 6.19 4.63 73.47 6.10 4.50
194 " " " "
##STR219##
C19 H18 N2 O5 354.35 Oil 40 64.40 5.12 7.91 64.25
5.27 7.92
195 " " " "
##STR220##
C17 H17 NO3 283.31 120 75 72.06 6.05 4.94 72.27 5.91
4.62
196 " " " "
##STR221##
C20 H18 N2 O3 334.36 127 70 71.84 5.43 8.38 71.89
5.36 8.45
197 " " " "
##STR222##
C18 H18 BrNO4 392.24 116 81 55.11 4.63 3.57 54.94 4.35
3.55
198 " " " "
##STR223##
C18 H18 NIO4 439.24 118 78 49.22 4.13 3.19 49.39 4.08
3.13
199 " " " "
##STR224##
C19 H18 N2 O4[α]D20 = -39°7
338.35(C = 1/CH2 Cl2) 83 75 67.44 5.36 8.28 67.14 5.53 8.38
200 " " " "
##STR225##
C19 H18 N2 O4[α]D20 = +32°1
338.35(C = 1/CH2 Cl2) 84 51 67.44 5.36 8.28 67.52 5.36 8.28
201 " " "
##STR226##
##STR227##
C20 H23 N3 O5 385.41 76 36 62.32 6.02 10.90 62.04
5.90 10.75
202 " " "
##STR228##
" C21 H23 N3 O6 413.42 138 26 61.01 5.61 10.17
61.11 5.67 10.01 203 " " " CH2NHEt " C19 H21 N3
O5 371.38 70 54 61.44 5.70 11.32 61.48 5.58 11.57 204 " " "
##STR229##
" C21 H23 N3 O5 397.42 110 24 63.46 5.83 10.57
63.16 5.90 10.39
205 " " " CH2NH2
##STR230##
C18 H17 N3 O3 323.34 94 10 66.86 5.30 13.00 66.73
5.58 12.69
206 " " "
##STR231##
" C20 H21 N3 O3 351.39 84 62 68.36 6.02 11.96 68.38
6.30 11.68 207 " " " CH2NH2
##STR232##
C17 H16 ClN3 O5 475.06 155 11 54.04 4.27 11.12
54.17 4.31 11.26 208 S " " CH2
OCOEt
##STR233##
C20 H20 N2 O6 S 416.44 126 73 57.68 4.84 6.73
57.59 5.03 6.69 209 " " " CH2
OH
##STR234##
C18 H15 FN2 O3 S 358.38 126 27 59.57 4.31 7.72
59.72 4.52 7.54 210 " " " CH2
OC3 H7n
##STR235##
C20 H22 N2 O5 S 402.46 110 57 59.68 5.51 6.96
59.57 5.65 7.19 211 " " " CH2
OCH3
##STR236##
C17 H23 NO3 S 321.43 68 35 63.52 7.21 4.36 63.61 7.43
4.33 212 " " " CH2 OH 4 O(CH2)3CN C14 H16
N2 O3 S 292.35 80 54 57.51 5.52 9.58 57.40 5.32 9.42 213 " "
" CH2
OCH3
##STR237##
C17 H18 N2 O3 S 460.95 133 17 51.85 4.57 6.08
51.68 4.40 6.04
214 " " " "
##STR238##
C16 H33 NO3 S 309.42 Oil 30 62.10 7.49 4.53 62.41 7.61
4.45 215 " " " CH2 OH 4 O(CH2)4CN C 15 H18
N2 O3 S 306.37 106 40 58.80 5.92 9.14 58.88 5.74 9.12 216 "
" " CH2
OEt
##STR239##
C19 H20 N2 O5 S 388.43 80 47 58.75 5.19 7.21 58.68
5.09 7.28 217 " " " CH2 OCH3 4 O(CH2)4CN C16
H20 N2 O3 S 320.40 Oil 24 59.97 6.29 8.74 59.81 6.28 9.02
218 " " " "
##STR240##
C19 H17 N3 O5 S 399.42 176 57 57.13 4.29 10.52
57.06 4.19 10.46
219 O S " "
##STR241##
C18 H18 N2 O5 S 374.41 74 47 57.74 4.85 7.48 57.45
4.97 7.18 220 H2 CH2 " CH2
OH
##STR242##
C18 H21 NO2 283.36 87 85 76.29 7.47 4.94 76.40 7.60
4.65
TABLE II
__________________________________________________________________________
##STR243## (IX)
Code Molecular
Melting Point
Yield
Elementary Analysis
Number
R6 Empirical Formula
Weight
(°C.)
% % C H N
__________________________________________________________________________
226 C3 H7n
C20 H23 NO4
341.39
105 62 Cal.
70.36
6.79
4.10
Obt.
70.17
6.80
3.86
227 Et C19 H21 NO4
327.37
105 58 Cal.
69.70
6.47
4.28
Obt.
69.44
6.48
4.23
228
##STR244##
C21 H25 NO4
355.42
107 61 Cal. Obt.
70.96 71.09
7.09 6.77
3.94 3.70
229
##STR245##
C 22 H27 NO4
369.44
101 61 Cal. Obt.
71.52 71.71
7.37 7.41
3.79 3.83
__________________________________________________________________________
TABLE III
__________________________________________________________________________
##STR246## (VIII)
Melting Point
Yield
ELEMENTARY ANALYSIS
Code Number
R'6 Empirical Formula
Molecular Weight
(°C.)
(%) C H N
__________________________________________________________________________
221
##STR247##
C13 H17 NO4
251.27 93 70 Cal. Obt.
62.14 62.14
6.82 6.80
5.57 5.56
222 CH3 C11 H13 NO4
223.22 106 81 Cal.
59.18
5.87
6.28
Obt.
59.15
6.01
6.38
223
##STR248##
C16 H21 NO4
291.34 108 92 Cal. Obt.
65.96 66.17
7.27 7.58
4.81 5.01
224 C3 H7n
C13 H17 NO4
251.27 88 78 Cal.
62.14
6.82
5.57
Obt.
62.16
6.53
5.60
__________________________________________________________________________
##STR249## (VIII)
Melting Point
Yield
ELEMENTARY ANALYSIS
Code Number
R'6 Empirical Formula
Molecular Weight
(°C.)
% % C H N
__________________________________________________________________________
230 Et C12 H15 NO4
237.25 86 81 Cal.
60.75
6.37
5.90
Obt.
60.60
6.21
5.83
231
##STR250##
C14 H19 NO4
265.30 98 85 Cal. Obt.
63.38 63.28
7.22 7.04
5.28 5.39
232
##STR251##
C15 H21 NO4
279.33 80 82 Cal. Obt.
64.49 64.30
7.58 7.42
5.01 4.84
__________________________________________________________________________

The compounds of formula (I) were studied on laboratory animals and showed activities in the psychotropic field, as potential anti-depressants.

These activities were revealed in the following tests:

Test A: Potentiation in mice of generalized trembling caused by an interperitoneal injection (200 mg/kg) of dl-5-hydroxytryptophane, following the protocol described by C. GOURET and G. RAYNAUD in J. Pharmacol. (Paris), (1974), 5, 231.

Test B: Antagonism with respect to the ptosis observed one hour after an intravenous injection (2 mg/kg) of reserpine given to mice, following the protocol described by C. GOURET and J. THOMAS in J. Pharmacol. (Paris), 1973, 4, 401.

The results of these two tests, as well as those of a well-know reference substance, TOLOXATONE, are collected in table IV below:

TABLE IV
______________________________________
Com-
pound
tested
Code Toxicity
Num- Test A Test B LD/50
ber ED/50/mg/kg/po
ED/50/mg/kg/po
Mouse/mg/kg/po
______________________________________
1 12.5 6.2
2 12.5 8
3 3.1 2.7 >2000
4 2.3 3.4
5 4.7 9.5
6 2.4 6
7 -- 7.4
8 2.2 7.2
9 -- 25
10 2.4 5.8
11 4.2 6.2
12 4.6 6
13 3 2 >2000
14 2 3.1
15 2.2 2
16 1.7 1.5
17 4.8 3.6
18 4 4.25
19 5.5 3.5
20 8.8 3.7
21 2.1 3.5
22 -- 3
23 12 12.5
24 9 12.5 >2000
25 15 25
26 12.5 20
27 25 44
28 32 20
29 45 50
30 4.2 4.5
31 6.5 3.6
32 4.7 3.6
33 9.4 4.5
34 7 7.5
35 19 6.5
36 1.7 1.5
37 1.9 2
38 1.5 2
39 1.75 1.6
40 6.2 1.5
41 6.2 4.5
42 1.25 2
43 15 17.5
44 6.2 --
45 45 50
46 1.5 2
47 18 36
48 50 50
49 0.5 0.4 2000
50 17.5 15
51 27 50
52 1.2 -- >2000
53 5 5.8
54 14 12.5
55 0.6 1.1
56 -- 3
57 7.8 9
58 50 8.8
59 3.4 3.1
60 30 --
61 0.08 0.1 1500
62 3.6 2.4
63 9.4 16.5
64 -- 4.5
65 0.28 0.75
66 4.7 6
67 4.4 5.6
68 5 6.2
69 0.5 0.2
70 0.8 0.6
71 1 0.8
72 0.8 1
73 0.6 0.8
74 4 6.2
75 8 --
76 2.1 6.2
77 2.5 6.2 >2000
78 6.2 --
79 6.2 2
80 20 25
81 24 25
82 9.6 12
83 12.5 6.2
84 3 1.3
85 3 2 1000
86 4.5 4.8
87 29 44
88 12.5 33
89 12.5 12.5
90 3 8
91 4.5 5.5 >2000
92 30 50
93 9 6
94 1.5 1 >2000
95 50 35
96 4.7 3.6
177 8 15.5
97 3.9 3.2
98 12.5 12.5
99 50 30 >2000
111 0.28 --
100 6.2 --
101 18 --
102 6.2 --
103 5 6
104 6.2 --
105 6.2 --
106 6.2 --
107 -- 12
108 5.6 --
109 0 1
110 0.3 --
112 0.1 0.15
TOL- 60 50
OXA-
TONE
114 3.7 2 >2000
115 3.8 4.8
116 1.6 0.95
117 1.2 1.5
118 1 0.1 >2000
119 -- 8
120 -- 3
121 11 8
122 6.8 6.2
123 2 1.4 >2000
124 -- 0.6
125 5 3.5
126 4.4 1.8
127 5 4.3
128 7.2 4.8
129 7.5 12
130 6.2 9.6
131 12 31
132 3 2 >2000
133 6 5.2
134 -- 3.9
135 -- 4.2
136 -- 31
137 -- 6
138 -- 6
142 18 17.5
143 12.5 12
144 2.2 1.1
145 8.5 12
146 5 12.5
147 1.5 2.6
148 2.2 --
149 6 --
152 18 15.5
153 3.8 4
______________________________________
Com-
pound
tested
Code Test A Test B Toxicity
num- ED50 ED50 LD50 Mouse
ber (mg/kg/po) (mg/kg/po) (mg/kg/po)
______________________________________
154 19 17.5
155 9.6 3
156 0.47 0.3
157 4.7 6.2
158 6 6
159 5.2 4.8
160 -- 4.2
161 1.1 0.36 >2000
162 0.54 1.55
163 1.15 8
170 12.5 16
171 19.5 25
172 -- 8.6
173 -- 4.7
175 5.8 9.6
176 4 4
150 0.7 0.5
151 5.2 5
164 3.4 3.4
165 6.8 4.7
166 3.8 3.4
167 3.7 3
168 25 16 >1000
169 3 4.1 >1000
174 3 3.5
113 3.2 3.5
178 33 28 >1000
179 4.5 7 >1000
180 7.4 7.8 1000 (20%)
181 4 9 >1000
182 3.7 5.8 >1000
183 1.9 2.4 >1000
184 1.2 0.72 >1000
185 12 7 >1000
186 3 3 >1000
187 2.7 1.3 >1000
188 0.3 0.4 --
189 2.6 0.9 >1000
190 1 0.23 >1000
191 0.4 0.38 1000 (40%)
192 5.8 6 >1000
193 19 30 --
194 6.4 5.8 --
195 1.2 2.2 >1000
196 -- 0.55 >1000
197 2.2 6.7 >1000
198 40 34 >1000
199 0.31 -- >1000
200 1.7 -- >1000
201 7.4 6.8 >1000
202 10 10 >1000
203 5.2 1.4 1000 (40%)
204 50 40 1000 (40%)
205 10.1 3 >1000
206 6 4.3 >1000
207 9.1 7.6 >1000
208 10 4.2 >1000
209 7 6.7 1000 (20%)
210 26 7.4 >1000
211 2 1.2 1000 (20%)
212 4.3 12 1000 (40%)
213 3 2 1000 (100%)
214 0.84 1.8 1000 (40%)
215 6.2 10 >1000
216 5 3 1000 (80%)
217 1 1 --
218 7.2 13.5 >1000
219 7 13.5 >1000
220 50 50 >1000
234 0.6 4 >1000
______________________________________

As can be seen from the results shown in table IV, the compounds of formula (I) have an activity greater than that of the reference compound.

They are indicated in endogenous and exogenous depressive conditions and will be administered orally in the form of tablets, pills or capsules, at a dosage of 50 to 500 mg/day on average, of active substance.

They will also be administered in the form of an injectable solution at the rate of 5-50 mg/day of active substance, the solvent used being formed by binary or ternary mixtures containing for example water, polypropyleneglycol or polyethyleneglycol (quality: 300-400), or any other physiologically acceptable solvent, the relative proportions of the different solvents being adjusted with respect to the dose administered.

Bourgery, Guy R., Langlois, Michel, Lacour, Alain P., Douzon, Colette A., Ancher, Jean-Francois R., Guerret, Patrick G., Dostert, Phillippe L.

Patent Priority Assignee Title
4705799, Jun 07 1983 Bristol-Myers Squibb Pharma Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
5399574, Jun 07 1990 AstraZeneca UK Limited Indolyl tetrahydropyridines for treating migraine
5466699, Jun 07 1990 AstraZeneca UK Limited Indolyl compounds for treating migraine
5863935, Jun 07 1990 AstraZeneca UK Limited Therapeutic heterocyclic compounds
6410734, Jul 17 2000 Wyeth 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
6537994, Jul 17 2000 Wyeth Heterocyclic β3 adrenergic receptor agonists
6569873, Jul 17 2000 Wyeth Azolidines as beta-3 adrenergic receptor agonists
6583140, Jul 17 2000 Wyeth 2-substituted thiazolidinones as beta-3 adrenergic receptor agonists
6617339, Jun 05 1998 Syngenta Limited Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
6649603, Jul 17 2000 Wyeth Cyclylamine sulfonamides as β3-adrenergic receptor agonists
6821991, Jul 17 2000 Wyeth 2-substituted thiazolidinones as β-3 adrenergic receptor agonists
7022716, Jul 17 2000 Wyeth Cyclic amine phenyl beta-3 adrenergic receptor agonists
7501528, Mar 15 2005 Hoffmann-La Roche Inc. Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives
8227505, Mar 15 2005 Hoffman-La Roche Inc. Method for preparing enantiomerically pure 4-pyrrolidino phenylbenzyl ether derivatives
Patent Priority Assignee Title
3687965,
4348393, Jun 09 1978 Delalande S.A. N-Aryl oxazolidinones, oxazolidinethiones, pyrrolidinones, pyrrolidines and thiazolidinones
FR2381038,
/
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jun 16 1982Delalande S.A.(assignment on the face of the patent)
Date Maintenance Fee Events
Jan 09 1989M170: Payment of Maintenance Fee, 4th Year, PL 96-517.
Jan 09 1989M176: Surcharge for Late Payment, PL 96-517.
Jan 12 1989ASPN: Payor Number Assigned.
Jul 04 1993EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Jul 02 19884 years fee payment window open
Jan 02 19896 months grace period start (w surcharge)
Jul 02 1989patent expiry (for year 4)
Jul 02 19912 years to revive unintentionally abandoned end. (for year 4)
Jul 02 19928 years fee payment window open
Jan 02 19936 months grace period start (w surcharge)
Jul 02 1993patent expiry (for year 8)
Jul 02 19952 years to revive unintentionally abandoned end. (for year 8)
Jul 02 199612 years fee payment window open
Jan 02 19976 months grace period start (w surcharge)
Jul 02 1997patent expiry (for year 12)
Jul 02 19992 years to revive unintentionally abandoned end. (for year 12)